Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With Depression

NCT03766867 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Vortioxetine infusion 25 mg
DRUG: Vortioxetine tablets 10 mg/day
DRUG: Placebo infusion
DRUG: Placebo tablets

Sponsor

H. Lundbeck A/S